APLM
Apollomics Inc. Class A Ordinary Shares
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$6.920
Haut
$6.920
Bas
$6.920
Volume
0.00M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew interim data for
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung
Actions Connexes
DHCNI
Diversified Healthcare Trust 5.625% Senior Notes due 2042
ATLCL
Atlanticus Holdings Corporation 6.125% Senior Notes due 2026
PBT
Permian Basin Royalty Trust
IKT
Inhibikase Therapeutics Inc.
VVI
Viad Corp
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.